Next Article in Journal
Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms
Next Article in Special Issue
New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity
Previous Article in Journal
2-Methylimidazole Copper Iminodiacetates for the Adsorption of Oxygen and Catalytic Oxidation of Cyclohexane
Previous Article in Special Issue
Anticancer Activities of Newly Synthesized Chiral Macrocyclic Heptapeptide Candidates
Open AccessReview

An Overview of the Potential Antineoplastic Effects of Casticin

1
Department of Pharmacology—Biomedicine, The University of Melbourne, Parkville, VIC 3010, Australia
2
Department of Biochemistry, Quaid-i-Azam University, Higher Education Commission of Pakistan, Islamabad 44000, Pakistan
3
Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, #47, Kyungheedae-gil, Dongdaemoon-gu, Seoul 130–701, Korea
*
Authors to whom correspondence should be addressed.
Academic Editors: Simona Collina and Mariarosaria Miloso
Molecules 2020, 25(6), 1287; https://doi.org/10.3390/molecules25061287
Received: 10 February 2020 / Revised: 9 March 2020 / Accepted: 9 March 2020 / Published: 12 March 2020
(This article belongs to the Special Issue Recent Advances in Anticancer Drugs II)
Cancer persists as one of the leading causes of deaths worldwide, contributing to approximately 9.6 million deaths per annum in recent years. Despite the numerous advancements in cancer treatment, there is still abundant scope to mitigate recurrence, adverse side effects and toxicities caused by existing pharmaceutical drugs. To achieve this, many phytochemicals from plants and natural products have been tested against cancer cell lines in vivo and in vitro. Likewise, casticin, a flavonoid extracted from the Vitex species, has been isolated from the leaves and seeds of V. trifolia and V. agnus-castus. Casticin possesses a wide range of therapeutic properties, including analgesic, anti-inflammatory, antiangiogenic, antiasthmatic and antineoplastic activities. Several studies have been conducted on the anticancer effects of casticin against cancers, including breast, bladder, oral, lung, leukemia and hepatocellular carcinomas. The compound inhibits invasion, migration and proliferation and induces apoptosis (casticin-induced, ROS-mediated and mitochondrial-dependent) and cell cycle arrest (G0/G1, G2/M, etc.) through different signaling pathways, namely the PI3K/Akt, NF-κB, STAT3 and FOXO3a/FoxM1 pathways. This review summarizes the chemo-preventive ability of casticin as an antineoplastic agent against several malignancies. View Full-Text
Keywords: cancer; casticin; flavonoid; apoptosis; PI3K/Akt; NF-κB; STAT3; FOXO3a/FoxM1 cancer; casticin; flavonoid; apoptosis; PI3K/Akt; NF-κB; STAT3; FOXO3a/FoxM1
Show Figures

Figure 1

MDPI and ACS Style

Ramchandani, S.; Naz, I.; Lee, J.H.; Khan, M.R.; Ahn, K.S. An Overview of the Potential Antineoplastic Effects of Casticin. Molecules 2020, 25, 1287.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop